Rachel Ware Miller MD
Gynecologic Oncology
Assistant Professor, Obstetrics & Gynecology, University of Kentucky College of Medicine
Join to View Full Profile
800 Rose St# 331Lexington, KY 40536
Phone+1 859-323-2169
Fax+1 859-323-1602
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kentucky College of MedicineFellowship, Gynecologic Oncology, 2010
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Obstetrics and Gynecology, 2003 - 2007- University of Kentucky College of MedicineClass of 2003
Certifications & Licensure
KY State Medical License 2007 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016
Clinical Trials
- Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma Start of enrollment: 2012 Mar 01
- Biobehavioral Intervention in Gynecologic Oncology Patients Start of enrollment: 2015 Jun 01
- Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies Start of enrollment: 2017 Apr 11
Publications & Presentations
PubMed
- Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor Malignancies.Allison L Swiecki-Sikora, Lydia Williams, Ning Li, Donglin Yan, Evan Bryson
JCO Precision Oncology. 2026-01-01 - 1 citationsCisplatin-Containing Combinations Associate with Survival in Women from Appalachian Kentucky with Metastatic, Persistent, or Recurrent Uterine Cervix Cancer.Charles A Kunos, Rachel W Miller, Denise Fabian
Cancers. 2024-09-28 - 1 citationsClinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports.Taylor A Rives, James Collard, Ning Li, Donglin Yan, Charles S Dietrich
JCO Precision Oncology. 2024-09-01
Press Mentions
Cervical Cancer Vaccination, Screening Highly Encouraged by U of Kentucky GynecologistJanuary 20th, 2017
Cervical Cancer Is Preventable, but Still Leading Cancer in KentuckyOctober 21st, 2013
Markey's Molecular Tumor Board Thriving in Its First YearMarch 23rd, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
